Arkstone’s Treatment Recommendations Now Include Realtime National Institutes of Health (NIH) Data
The NIH has been collecting lab result isolate data for decades, compiling information about the prevalence of antimicrobial resistance genes in specific organisms.
Arkstone’s OneChoice Treatment Recommendations Now Include Renal and Hepatic Reference Adjustments
Now, providers have access to detailed and dynamic renal and hepatic dosing adjustments for any treatment recommendations provided.
Arkstone Now Factors Pregnancy for the OneChoice Report and MedsMatrix
Many healthcare providers treating infections in a pregnant patient have difficulty finding the best treatment, while also taking into consideration an antimicrobial that will have the lowest risk to the fetus.
Ovation Announces Partnership with Arkstone to Provide Actionable Antibiotic Treatment Recommendations
Ovation LIMS/LIS enables prominent molecular diagnostic laboratories to provide comprehensive test results to thousands of clinicians nationwide. Now, these labs can deliver the Arkstone OneChoice report combined with the patient’s detected pathogens and antibiotic resistance genes outlined in the infectious disease laboratory results.
Arkstone’s Launches Revolutionary MedsMatrix
MedsMatrix expands on OneChoice by giving the provider a clear understanding of what different treatment options are, and even some insight into how the OneChoice decision engine came to its conclusions
Juan Carlos Gómez de la Torre becomes Arkstone’s Director of Molecular Informatics
Dr. Juan Carlos Gómez de la Torre Pretell, founder of the Peruvian Institute of Molecular Biology, will be an integral part of Arkstone’s advancements in the use of artificial intelligence to democratize infectious disease expertise and increase antibiotic stewardship.
Arkstone’s Antimicrobial Stewardship Program (ASP) Provides Skilled Nursing Facilities with Advanced Cost Effective Program
The Antimicrobial Stewardship Monthly Report includes month-to-month tracking of infections from many different sources, including respiratory, wound, urine, and GI. The report breaks down the most common types of infections and resistance genes and analyzes this data so that trends are easily visible, allowing for the implementation of proactive surveillance and infection control policies.
Arkstone Updates ArkScore System to Provide Unmatched Physician Experience
The improved ArkScore interprets the complex results of a molecular diagnostic test and presents an optimal course of treatment. This simplification allows each physician to quickly understand how treatment options are affected by the patient’s profile, presence of specific organisms, and resistance genes.